EXCLUSIVE LICENSE AGREEMENT by and between ORGANON INTERNATIONAL GMBH and DARÉ BIOSCIENCE, INC.Exclusive License Agreement • May 12th, 2022 • Dare Bioscience, Inc. • Pharmaceutical preparations • Delaware
This Exclusive License Agreement (this “Agreement”) is entered as of March 31, 2022 (the “Execution Date”) by and between Organon International GmbH, a limited liability company organized and existing under the laws of Switzerland (“Organon”) and Daré Bioscience, Inc., a corporation organized and existing under the laws of Delaware (“Daré”).
CONSENT, WAIVER AND STAND-BY LICENSE AGREEMENTConsent, Waiver and Stand-by License Agreement • May 12th, 2022 • Dare Bioscience, Inc. • Pharmaceutical preparations • Delaware
This CONSENT, WAIVER AND STAND-BY LICENSE AGREEMENT (this “Agreement”), dated March 30, 2022 (“Execution Date”), is by and among TriLogic Pharma, LLC, a limited liability company organized under the laws of Delaware (“TriLogic”), MilanaPharm LCC, a limited liability company organized under the laws of Delaware (“MilanaPharm”), Daré Bioscience, Inc., a corporation organized and existing under the laws of Delaware (“Daré”), and Organon International GmbH, a limited liability company organized and existing under the laws of Switzerland (“Organon”).
